Spore.Bio Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 34

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $23M

  • Investors
  • 21

Spore.Bio General Information

Description

Developer of a bacterial detection technology designed to develop innovative technological tools to help the food and beverage industry. The company offers a new generation of microbiological technologies directly usable on the shop floor, combining cutting-edge optical technology with advanced machine-learning models, enabling cosmetics and pharmaceutics factories to help factories manufacture safe products.

Contact Information

Website
www.spore.bio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 27 Rue du Fbg Saint-Jacques
  • 75014 Paris
  • France
Primary Industry
Other Commercial Products
Other Industries
Biotechnology
Vertical(s)
Manufacturing, Artificial Intelligence & Machine Learning, Life Sciences
Corporate Office
  • 27 Rue du Fbg Saint-Jacques
  • 75014 Paris
  • France

Spore.Bio Timeline

202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Spore.Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Early Stage VC (Series A) 19-Feb-2025 $23M Completed Startup
5. Seed Round 12-Dec-2023 Completed Startup
4. Accelerator/Incubator 01-Jan-2023 Completed Startup
3. Accelerator/Incubator 01-Jan-2023 Completed Startup
2. Accelerator/Incubator Completed Startup
1. Accelerator/Incubator Completed Startup
To view Spore.Bio’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Spore.Bio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a bacterial detection technology designed to develop innovative technological tools to help the food and be
Other Commercial Products
Paris, France
34 As of 2025

Toronto, Canada
 

Scottsdale, AZ
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Spore.Bio Competitors (2)

One of Spore.Bio’s 2 competitors is Phenomic AI, a Venture Capital-Backed company based in Toronto, Canada.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Phenomic AI Venture Capital-Backed Toronto, Canada
PathogenDx Venture Capital-Backed Scottsdale, AZ
You’re viewing 2 of 2 competitors. Get the full list »

Spore.Bio Patents

  • 3

    Total Documents Applications and Grants

  • Total Patents Families

  • 3

    Granted

  • Pending

  • Expiring in next 12 mo

Spore.Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3385703-A1 Improved spectroscopic device and method for sample characterization Active 07-Apr-2017
EP-3385703-B1 Improved spectroscopic device and method for sample characterization Active 07-Apr-2017
EP-3385703-C0 Improved spectroscopic device and method for sample characterization Active 07-Apr-2017 G01N21/314

Spore.Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Spore.Bio Investors (21)

Investor Name Investor Type Holding Investor Since Participating Rounds
Angel (individual) Minority
Point72 Ventures Venture Capital Minority
Singular. Venture Capital Minority
Station F Accelerator/Incubator Minority
1st Kind Venture Capital Minority
You’re viewing 5 of 21 investors. Get the full list »

Spore.Bio Acquisitions (1)

Spore.Bio’s most recent deal was a Merger/Acquisition with GreenTropism.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
GreenTropism Merger/Acquisition Biotechnology
To view Spore.Bio’s complete acquisitions history, request access »

Ready to get started?

Request a free trial

Spore.Bio FAQs

  • When was Spore.Bio founded?

    Spore.Bio was founded in 2022.

  • Where is Spore.Bio headquartered?

    Spore.Bio is headquartered in Paris, France.

  • What is the size of Spore.Bio?

    Spore.Bio has 34 total employees.

  • What industry is Spore.Bio in?

    Spore.Bio’s primary industry is Other Commercial Products.

  • Is Spore.Bio a private or public company?

    Spore.Bio is a Private company.

  • What is Spore.Bio’s current revenue?

    The current revenue for Spore.Bio is .

  • How much funding has Spore.Bio raised over time?

    Spore.Bio has raised $31.8M.

  • Who are Spore.Bio’s investors?

    , Point72 Ventures, Singular., Station F, and 1st Kind are 5 of 21 investors who have invested in Spore.Bio.

  • Who are Spore.Bio’s competitors?

    Phenomic AI and PathogenDx are competitors of Spore.Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »